Healthy high growth potential

Results

1525

Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.

1525 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
CDR
zł261.205.1%5.9%zł26.1bzł234.5150.539.0%0.4%Media
AXSM
US$213.681.7%96.5%US$11.2bUS$285.4214.461.2%n/aPharmaceuticals & Biotech
KEBNI B
SEK 1.127.3%-50.3%SEK 305.5mSEK 1.252.790.9%n/aTech
LPK
€15.702.3%96.3%€383.9m€22.753.9116.6%0%Tech
AAZ
UK£4.15-0.6%159.4%UK£474.5mUK£5.6836.225.9%0.7%Materials
WAYS
SEK 39.200.5%-3.4%SEK 343.8mSEK 58.00208.678.5%0%Tech
AGP
€7.302.7%-6.2%€133.1m€8.5726.839.1%n/aCapital Goods
FWRY
ج.م19.01-1.2%44.0%ج.م64.8bج.م22.4524.327.3%n/aDiversified Financials
MDGL
US$507.37-0.6%36.6%US$12.4bUS$678.069.163.7%n/aPharmaceuticals & Biotech
SAUD3
R$13.72-3.3%7.2%R$40.1bR$17.6938.131.9%5.9%Healthcare
509496
₹1,299.157.4%69.2%₹223.2b₹1,589.6737.129.9%0.2%Capital Goods
688072
CN¥688.20-0.4%314.1%CN¥199.2bCN¥681.93121.146.8%0.05%Semiconductors
002810
CN¥20.13-0.5%47.5%CN¥7.0bCN¥36.0034.943.1%2.0%Materials
688183
CN¥115.99-2.3%111.3%CN¥96.1bCN¥159.0056.035.5%0.8%Tech
688192
CN¥60.918.8%-28.5%CN¥28.3bCN¥83.0031.7104.5%n/aPharmaceuticals & Biotech
3036
NT$210.00-0.7%67.3%NT$266.5bNT$314.8610.928.9%3.7%Tech
2480
HK$13.10-3.7%-44.3%HK$2.6bHK$31.003.477.1%n/aPharmaceuticals & Biotech
688700
CN¥57.82-7.9%23.0%CN¥17.2bCN¥61.6797.061.7%0.3%Capital Goods
NORTHERN
RM 0.690.7%-2.8%RM 271.0mRM 1.0017.739.5%n/aCapital Goods
543273
₹2,731.508.2%228.1%₹69.3b₹2,500.0087.953.9%n/aTransportation
2315
HK$69.0011.7%180.0%HK$65.7bHK$62.0391.241.0%n/aPharmaceuticals & Biotech
688300
CN¥164.658.5%181.8%CN¥39.8bCN¥151.00132.037.0%0.3%Materials
325
HK$73.6031.4%-35.9%HK$18.1bHK$80.2821.524.2%n/aConsumer Durables
301345
CN¥254.570.3%51.5%CN¥27.8bCN¥320.3530.631.5%1.2%Automobiles
Page 1 of 43